EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Preoperative alkaline phosphatase‐to‐platelet count ratio as a prognostic factor for hepatocellular carcinoma with microvascular invasion

Yongxin Zhang iD, Bin Zhang, Lianggeng Gong, Liangxia Xiong, Xuehong Xiao, Chao Bu, Zhiying Liang, Liangcai Li, Binghang Tang, Yangbai Lu

Cancer Medicine · 2023

DOI: 10.1002/cam4.6368 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2023. Verfasst von Yongxin Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of MR, Zhongshan City People's Hospital, Zhongshan, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Alkaline Phosphatase. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Major Project of Scientific Research Foundation, Zhongshan city people's hospital, National Natural Science Foundation of China, National Natural Science Foundation of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

The association between platelet status and hepatocellular carcinoma (HCC) prognoses remains controversial. Herein, we aimed to clarify the prognostic value of multiple platelet‐related biomarkers, including platelet count, platelet/lymphocyte ratio (PLR), aspartate aminotransferase to platelet ratio index (APRI), and alkaline phosphatase‐to‐platelet count ratio index (APPRI) in HCC with microvascular invasion (MVI) after curative resection or liver transplantation. Materials and Methods A retrospective review of 169 patients with solitary HCC and MVI who underwent resection or liver transplantation between January 2015 and December 2018 was conducted. Preoperative clinical, laboratory, pathologic, and imaging data were collected and analyzed. Overall survival (OS) and disease‐free survival (DFS) were defined as the clinical endpoints. Univariate and multivariate Cox proportional hazards regression analyses were conducted to investigate potential predictors of DFS and OS.

Results

Multivariate Cox regression analyses revealed that maximum tumor diameter, poor cell differentiation, and APPRI were independent predictors of DFS; while poor cell differentiation, APRI, APPRI, prothrombin time, and alpha‐fetoprotein were independent prognostic factors for OS. The 1‐, 3‐, and 5‐year DFS rates were 66.90%, 48.40%, and 37.40% for patients with APPRI ≤0.74 and 40.40%, 24.20%,and 24.20% for patients with APPRI>0.74. The corresponding rates of OS over 1, 3, and 5 years were 92.40%, 88.10% and 77.70%, and 72.30%, 38.20%, and 19.10%, respectively. The DFS and OS rates of patients whose APPRI was more than 0.74 were substantially lower than those of patients whose APPRI was less than or equal to 0.74 ( p = 0.002 and p < 0.001, respectively).

Conclusion

Elevated preoperative APPRI is a noninvasive, simple, and easily assessable parameter linked to poor prognosis in individuals with single HCC and MVI after resection or liver transplantation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsAlkaline PhosphataseHumansMaleFemaleMiddle AgedPlatelet CountRetrospective StudiesPrognosisNeoplasm InvasivenessAgedLiver TransplantationAdultMicrovesselsPreoperative PeriodBiomarkers, TumorHepatectomyBlood Platelets

Stichwörter der Autor:innen

aspartate aminotransferase to platelet ratiodisease-free survivalhepatocellular carcinomaoverall survival

Substanzen

Alkaline PhosphataseBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of MR, Zhongshan City People's Hospital, Zhongshan, China.
  • Department of Radiology, The First Affiliated Hospital of Jinan University, Guangzhou, China.
  • Department of Medical Imaging Center, The second affiliated Hospital of Nanchang University, Nanchang, China.
  • Department of Radiology, The Seventh Affiliated Hospital Sun Yat-Sen University, Shenzhen, China.
  • Department of Radiology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen Univ…
  • Department of CT, Zhongshan City People's Hospital, Zhongshan, China.

ORCID-Profile: Yongxin Zhang

Förderung

  • Major Project of Scientific Research Foundation, Zhongshan city people's hospital
  • National Natural Science Foundation of China
  • National Natural Science Foundation of Guangdong Province
  • the Scientific Research Cultivation and Innovation Foundation of Jinan University

Zitieren

APA

Zhang, Y., Zhang, B., Gong, L., Xiong, L., Xiao, X., Bu, C., Liang, Z., Li, L., Tang, B., & Lu, Y. (2023). Preoperative alkaline phosphatase‐to‐platelet count ratio as a prognostic factor for hepatocellular carcinoma with microvascular invasion. Cancer Medicine. https://doi.org/10.1002/cam4.6368

Vancouver

Zhang Y, Zhang B, Gong L, Xiong L, Xiao X, Bu C, et al. Preoperative alkaline phosphatase‐to‐platelet count ratio as a prognostic factor for hepatocellular carcinoma with microvascular invasion. Cancer Medicine. 2023. doi:10.1002/cam4.6368

BibTeX
@article{Zhang2023,
  author = {Zhang, Yongxin and Zhang, Bin and Gong, Lianggeng and Xiong, Liangxia and Xiao, Xuehong and Bu, Chao and Liang, Zhiying and Li, Liangcai and Tang, Binghang and Lu, Yangbai},
  title = {Preoperative alkaline phosphatase‐to‐platelet count ratio as a prognostic factor for hepatocellular carcinoma with microvascular invasion},
  journal = {Cancer Medicine},
  year = {2023},
  doi = {10.1002/cam4.6368}
}
Kostenlos starten →